Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shiwei Wenshen Wan is a Traditional Chinese Medicine (TCM) and Tibetan medicine formula primarily used to treat kidney-yang deficiency and associated reproductive health issues. The name translates to "Ten-Ingredient Kidney-Warming Pill," reflecting its composition of ten distinct herbal and mineral components. It is clinically indicated for conditions such as erectile dysfunction, premature ejaculation, and lower back pain or fatigue attributed to "kidney cold." In clinical research, it is often studied as an adjunctive therapy alongside phosphodiesterase-5 (PDE5) inhibitors like tadalafil to enhance therapeutic outcomes in patients with sexual dysfunction. The formula is registered as a pharmaceutical product in China and is manufactured by several companies specializing in traditional and Tibetan medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shiwei wenshen wan.